An amylin-analog research peptide seen in public records, sometimes as a Cagrilintide/Semaglutide (CagriSema) blend.
Within this directory, Cagrilintide appears in 2 summarized public testing-style records across 3 supplier listings. All figures are informational snapshots and may change as records are updated.
| Product | Supplier | Testing Category | Reported Result | Record |
|---|---|---|---|---|
| Cagrilintide 5mg | PeptideGurus | Cagrilintide analysis | Not publicly listed | 2025 |
| Cagrilintide 10mg + Semaglutide 10mg | UWA Biotech | Blend analysis | Not publicly listed | 2025 |
Cagrilintide is a research compound in the GLP-1 Research category. This page is informational and for research-use only; it does not provide dosage, human-use instructions, or medical claims.
Our directory currently summarizes 2 public testing-style records associated with Cagrilintide, across 3 supplier listings. Records are informational and may contain errors or omissions.
Look for a product name match, a batch or lot number, a testing date, the testing method (such as HPLC or LC-MS), and any publicly reported purity or amount. Missing fields can be a red flag.
No. Push for Peptides is an informational directory. It does not sell products, does not process payments, and does not provide medical advice. You can submit a supplier match request instead.
Submit a supplier match request and tell us what research-use product category you are looking for. Push for Peptides does not sell prescription medications and does not provide medical advice.